Becky Bish | The Mark Foundation for Cancer Research
Nomura in his lab at UC Berkeley. Photo: Elena Zhukova
Throughout the grim reality of a global pandemic that has disrupted normal life for months, one persistent bright spot has been the robust response of the biomedical research community. The battle to develop vaccines and drugs to fight the SARS-CoV-2 virus and COVID-19, the disease which it causes,...
Seniors Brendan Huang and Carolyn Hong, who both have received the COVID-19 vaccine and are in the same social bubble, met in an organic chemistry lab as sophomores, became fast friends and wound up baking sourdough bread together. It’s an adventure that Hong calls “our sourdough journey.” (Photo by Talia Patt...
Visionary biochemist Jennifer Doudna shared the Nobel Prize last year for the gene-editing technology known as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), which has the potential to cure diseases caused by genetic mutations. Correspondent David Pogue talks with Doudna about the promises and perils of CRISPR; and with Walter Isaacson, author of the new book "The Code Breaker," about why the biotech revolution will dwarf the digital revolution in importance.
Scientist makes COVID discovery in lab. (Photo Adobe Stock)
Since my colleagues and I first described CRISPR as a genome-engineering tool in 2012, the technique has transformed fundamental research. More than 15,000 papers containing the term have been published, hundreds of different organisms have been edited and this...
Katia Gibson, (B.S. '21, Chem) surfing last August at Jalama Beach in Santa Barbara County, brought along two surfboards, to get practice time on each. (Photo by Steve Gibson)
The COVID-19 pandemic has separated us, but sharing stories about how members of the campus community have been surviving — and even thriving — since...
In the diagnostic test, a patient sample is mixed with CRISPR Cas13 proteins (purple) and molecular probes (green) which fluoresce, or light up, when cut. When coronavirus RNA is present in the sample, it prompts the CRISPR proteins to snip the molecular probes, causing the whole sample to emit light. This fluorescence can be detected with a...
Jennifer Doudna talks with Alex Ehrenberg, a graduate student in integrative biology who is helping organize the FAST trial of saliva tests for COVID-19. Photo: UC Berkeley/Irene Yi
Researchers have used CRISPR gene-editing technology to come...
Teresa Head-Gordon, Chancellor's Professor of Chemistry, Bioengineering, and Chemical and Biomolecular Engineering, joins three colleagues from Berkeley Engineering who have received funding from the C3.ai Digital Transformation Institute for COVID-19 projects.
Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva. Saliva, collected in the same way companies like 23andMe and Ancestry.com get samples for DNA genealogy analysis, can be gathered without medical supervision, and that saves time, money and precious PPE.
